• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后骨质疏松症:文献综述

Postmenopausal Osteoporosis: A Literature Review.

作者信息

Bhatnagar Aayushi, Kekatpure Aditya L

机构信息

Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, IND.

Department of Orthopedic Surgery, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, IND.

出版信息

Cureus. 2022 Sep 20;14(9):e29367. doi: 10.7759/cureus.29367. eCollection 2022 Sep.

DOI:10.7759/cureus.29367
PMID:36299953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9586717/
Abstract

A substantial proportion of the population of females in India falls in the perimenopausal and postmenopausal age groups. One of the complications associated with older age in women is the weakening of bones and the fall in bone mineral density (BMD). This has a severe debilitating consequence in a woman's life and leads to reduced quality of life along with a greater incidence of fractures. If the fracture involves the hip or the vertebrae, it can cause immobility and be devastating. Postmenopausal osteoporosis is linked with the deficiency of estrogen that occurs with the cessation of the function of the ovaries as age progresses. The function of estrogen in the bone remodeling process is very well understood after years of research; estrogen plays a part in both the formation of bone as well as the prevention of the resorption of bone. A diagnosis can be made by dual-energy X-ray absorptiometry (DEXA). It is the gold standard and can spot low bone density at particular sites. The treatment options are selected according to the severity and rate of progression and factors pertaining to each patient. All postmenopausal women should be made aware of this disorder, and they should be encouraged to cultivate a healthy lifestyle through the implementation of a proper diet and inculcation of a regular exercise routine. Smoking and drinking alcohol should be limited, and calcium and vitamin D supplementation should be started in all women of the postmenopausal age group with or without osteoporosis. In patients who have been diagnosed with the disorder, pharmacological intervention is done. Drugs should be selected based on their side effects and contradictions. Follow-up is essential, and patient compliance should be carefully monitored. This article attempts to review the existing literature on this very prevalent disorder to spread awareness about it so that all postmenopausal women can take the necessary steps to prevent the weakening of their bones, and deal with its progression.

摘要

印度很大一部分女性人口处于围绝经期和绝经后年龄组。女性年龄增长所伴随的并发症之一是骨骼变弱和骨矿物质密度(BMD)下降。这在女性生活中会产生严重的衰弱后果,导致生活质量下降,同时骨折发生率更高。如果骨折累及髋部或脊椎,可能会导致行动不便,后果严重。绝经后骨质疏松症与随着年龄增长卵巢功能停止而出现的雌激素缺乏有关。经过多年研究,雌激素在骨重塑过程中的作用已得到充分了解;雌激素在骨形成以及防止骨吸收方面都发挥作用。可以通过双能X线吸收法(DEXA)进行诊断。它是金标准,能够发现特定部位的低骨密度。治疗方案根据严重程度、进展速度以及每个患者的相关因素来选择。所有绝经后女性都应该了解这种疾病,并且应该鼓励她们通过实施合理饮食和养成定期锻炼的习惯来培养健康的生活方式。应该限制吸烟和饮酒,所有绝经后年龄组的女性,无论是否患有骨质疏松症,都应该开始补充钙和维生素D。对于已被诊断患有该疾病的患者,要进行药物干预。应根据药物的副作用和禁忌来选择药物。随访至关重要,要仔细监测患者的依从性。本文试图回顾关于这种非常普遍疾病的现有文献,以提高对此的认识,以便所有绝经后女性能够采取必要措施预防骨骼变弱,并应对其进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b65/9586717/2584b29bce78/cureus-0014-00000029367-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b65/9586717/2ca3c8f6fa9c/cureus-0014-00000029367-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b65/9586717/717eff44d6fc/cureus-0014-00000029367-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b65/9586717/f9cbd253ca0f/cureus-0014-00000029367-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b65/9586717/2584b29bce78/cureus-0014-00000029367-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b65/9586717/2ca3c8f6fa9c/cureus-0014-00000029367-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b65/9586717/717eff44d6fc/cureus-0014-00000029367-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b65/9586717/f9cbd253ca0f/cureus-0014-00000029367-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b65/9586717/2584b29bce78/cureus-0014-00000029367-i04.jpg

相似文献

1
Postmenopausal Osteoporosis: A Literature Review.绝经后骨质疏松症:文献综述
Cureus. 2022 Sep 20;14(9):e29367. doi: 10.7759/cureus.29367. eCollection 2022 Sep.
2
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.安大略省双能X线吸收法骨密度测定的应用:基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.
3
A Comprehensive Review on Postmenopausal Osteoporosis in Women.女性绝经后骨质疏松症综合综述
Cureus. 2023 Nov 9;15(11):e48582. doi: 10.7759/cureus.48582. eCollection 2023 Nov.
4
5
[The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].[激素替代疗法对绝经后女性骨密度的影响:取决于维生素D受体(VDR)和雌激素受体(ER)基因的多态性]
Ann Acad Med Stetin. 2003;49:111-30.
6
Bone mineral densitometry substantially influences health-related behaviors of postmenopausal women.骨密度测定对绝经后女性与健康相关的行为有重大影响。
Calcif Tissue Int. 2000 Feb;66(2):113-8. doi: 10.1007/s002230010024.
7
Effectiveness and safety of vitamin D in relation to bone health.维生素D对骨骼健康的有效性与安全性。
Evid Rep Technol Assess (Full Rep). 2007 Aug(158):1-235.
8
Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.绝经后妇女骨质疏松症的管理:北美绝经学会 2010 年立场声明。
Menopause. 2010 Jan-Feb;17(1):25-54; quiz 55-6. doi: 10.1097/gme.0b013e3181c617e6.
9
Osteodensitometry in healthy postmenopausal women.健康绝经后女性的骨密度测定
Prescrire Int. 2008 Apr;17(94):68-72.
10
[Therapeutic concepts in the treatment of postmenopausal osteoporosis].[绝经后骨质疏松症的治疗理念]
Ther Umsch. 1994 Nov;51(11):737-47.

引用本文的文献

1
Study on the alteration of gut microbiota in ovariectomized rats and the impact of estrogen intervention over a 3-month period.去卵巢大鼠肠道微生物群的变化及雌激素干预3个月的影响研究。
PLoS One. 2025 Sep 4;20(9):e0330108. doi: 10.1371/journal.pone.0330108. eCollection 2025.
2
Synergistic Effects of an Eight-Week Resistance Training and Probiotic Supplementation on Bone Metabolism in Ovariectomized Rats.为期八周的抗阻训练与补充益生菌对去卵巢大鼠骨代谢的协同作用。
Prev Nutr Food Sci. 2025 Aug 31;30(4):323-330. doi: 10.3746/pnf.2025.30.4.323.
3
Clinical and biochemical efficacy zoledronic acid and denosumab combination: focus serum inflammatory factor level (serum ifcs), bone gla protein (bgp), and bone turnover markers b-collagen degradation product (b-ctx), and procollagen type 1 n-terminal propeptide (p1np).

本文引用的文献

1
Menopausal osteoporosis: screening, prevention and treatment.更年期骨质疏松症:筛查、预防和治疗。
Singapore Med J. 2021 Apr;62(4):159-166. doi: 10.11622/smedj.2021036.
2
Re-thinking the bone remodeling cycle mechanism and the origin of bone loss.重新思考骨重塑周期机制和骨丢失的起源。
Bone. 2020 Dec;141:115628. doi: 10.1016/j.bone.2020.115628. Epub 2020 Sep 10.
3
Biological basis of bone strength: anatomy, physiology and measurement.骨骼强度的生物学基础:解剖学、生理学和测量。
唑来膦酸与地诺单抗联合应用的临床及生化疗效:聚焦血清炎症因子水平(血清IFCs)、骨钙素(BGP)以及骨转换标志物I型胶原降解产物(β-CTX)和I型前胶原氨基端前肽(P1NP)。
J Med Biochem. 2025 Jun 13;44(3):587-594. doi: 10.5937/jomb0-51444.
4
Inflammaging-Driven Osteoporosis: Is a Galectin-Targeted Approach Needed?炎症衰老驱动的骨质疏松症:是否需要靶向半乳糖凝集素的方法?
Int J Mol Sci. 2025 Jul 4;26(13):6473. doi: 10.3390/ijms26136473.
5
The role of body composition and visceral fat in osteoporosis subtype differentiation: Insights from bioelectrical impedance analysis.身体成分和内脏脂肪在骨质疏松症亚型分化中的作用:生物电阻抗分析的见解
J Orthop. 2025 Jun 18;65:276-282. doi: 10.1016/j.jor.2025.06.014. eCollection 2025 Jul.
6
Decreased Bone Mineral Density Is Associated with Subclinical Atherosclerosis in Asymptomatic Non-Diabetic Postmenopausal Women.骨密度降低与无症状非糖尿病绝经后女性的亚临床动脉粥样硬化相关。
J Clin Med. 2025 Jun 6;14(12):4033. doi: 10.3390/jcm14124033.
7
Optimization of high-intensity resistance exercise protocols for improving bone mineral density in the elderly without chronic diseases: a systematic review and network meta-analysis.优化高强度抗阻运动方案以改善无慢性疾病老年人的骨密度:一项系统评价和网状Meta分析
Front Physiol. 2025 Jun 10;16:1589200. doi: 10.3389/fphys.2025.1589200. eCollection 2025.
8
Investigation of the correlation between radiomorphometric indices in cone-beam computed tomography images and dual X-ray absorptiometry bone density test results in postmenopausal women.锥束计算机断层扫描图像中的放射形态计量学指标与绝经后女性双能X线吸收法骨密度检测结果之间的相关性研究。
BMC Med Imaging. 2025 Jun 5;25(1):203. doi: 10.1186/s12880-025-01739-5.
9
Five-Year Sales Trends of Osteoporosis Medications in Korea: A Market Analysis Based on IMS Health Sales Audit Data (2018-2023).韩国骨质疏松症药物的五年销售趋势:基于艾美仕市场研究公司销售审计数据(2018 - 2023年)的市场分析
Medicina (Kaunas). 2025 Apr 26;61(5):805. doi: 10.3390/medicina61050805.
10
Leveraging Nanoscience and Strategic Delivery for the Expedition of Osteoporosis.利用纳米科学与战略交付推动骨质疏松症研究进展
AAPS PharmSciTech. 2025 May 9;26(5):129. doi: 10.1208/s12249-025-03120-9.
J Musculoskelet Neuronal Interact. 2020 Sep 1;20(3):347-371.
4
Determinants of imminent fracture risk in postmenopausal women with osteoporosis.绝经后骨质疏松症妇女即将发生骨折的风险因素。
Osteoporos Int. 2020 Nov;31(11):2103-2111. doi: 10.1007/s00198-020-05294-3. Epub 2020 Jul 1.
5
Genetic Predisposition for Osteoporosis and Fractures in Postmenopausal Women.绝经后妇女骨质疏松症和骨折的遗传易感性。
Adv Exp Med Biol. 2019;1211:17-24. doi: 10.1007/5584_2019_413.
6
Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women.绝经后妇女骨质疏松症的诊断和管理欧洲指南摘要
Calcif Tissue Int. 2019 Mar;104(3):235-238. doi: 10.1007/s00223-018-00512-x.
7
Calcium Intake in Bone Health: A Focus on Calcium-Rich Mineral Waters.钙摄入与骨骼健康:关注富含钙的矿泉水。
Nutrients. 2018 Dec 5;10(12):1930. doi: 10.3390/nu10121930.
8
European guidance for the diagnosis and management of osteoporosis in postmenopausal women.欧洲绝经后妇女骨质疏松症的诊断和管理指南。
Osteoporos Int. 2019 Jan;30(1):3-44. doi: 10.1007/s00198-018-4704-5. Epub 2018 Oct 15.
9
Bone Mechanical Properties in Healthy and Diseased States.健康与患病状态下的骨骼力学特性
Annu Rev Biomed Eng. 2018 Jun 4;20:119-143. doi: 10.1146/annurev-bioeng-062117-121139.
10
Cortical or Trabecular Bone: What's the Difference?皮质骨还是松质骨:有何区别?
Am J Nephrol. 2018;47(6):373-375. doi: 10.1159/000489672. Epub 2018 May 22.